natgillin/translations-raw huggingface dataset:
For elderly people 65 years of age or older, the starting dose is 5 mg vortioxetine taken once daily.
Za starije osobe u dobi 65 godina ili starije, početna doza je 5 mg vortioksetina koja se uzima jednom dnevno.
No significant effects, relative to placebo, were observed in the levels of sex hormones following co-administration of vortioxetine with a combined oral contraceptive (ethinyl estradiol 30 µg/ levonorgestrel 150 µg).
Nisu bili opaženi značajni učinci na nivo spolnih hormona u usporedbi s placebom, nakon istodobne primjene vortioksetina i kombinacije oralnih kontraceptiva (etinil estradiol 30 µg/levonorgestrel 150 µg).
The European Medicines Agency has deferred the obligation to submit the results of studies in major depressive disorder with vortioxetine in children and adolescents aged 7 to 18 years (see section 4.2 for information on paediatric use).
Europska agencija za lijekove je odgodila obvezu podnošenja rezultata ispitivanja lijeka vortioksetin kod velike depresivne epizode u djece i adolescenata u dobi od 7 do 18 godina (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni)
In a pre- and post-natal study in rats, vortioxetine was associated with increased pup mortality, reduced bodyweight gain, and delayed pup development at doses that did not result in maternal toxicity and with associated exposures similar to those achieved in humans following administration of vortioxetine 20 mg/day (see section 4.6).
U prenatalnom i postnatalnom ispitivanju u štakora vortioksetin je povezan s povećanom smrtnošću mladunčadi, smanjenim prirastom tjelesne težine te odgođenim razvojem mladunčadi pri dozama koje nisu rezultirale maternalnom toksičnošću te s povezanim izloženostima sličnim onima postignutima u ljudi nakon primjene vortioksetina 20 mg/dan (vidjeti dio 4.6).
Twelve double-blind, placebo-controlled, 6/8-week, fixed-dose studies have been conducted to investigate the short-term efficacy of vortioxetine in MDD in adults (including the elderly).
Provedeno je dvanaest dvostruko slijepih placebom kontroliranih, 6/8 tjednih ispitivanja fiksnih doza kako bi se istražila kratkoročna djelotvornost vortioksetina kod MDD-a u odraslih (uključujući starije osobe).
The most common adverse reaction was nausea.
Najčešća nuspojava bila je mučnina.
You may be more likely to think like this if you: - have previously had thoughts about killing or harming yourself.
Možda ćete biti skloniji takvim mislima ako: - ste prije imali misli o samoozljeđivanju ili samoubojstvu. - ste mlada odrasla osoba.
Lithium, tryptophan
Litij, triptofan
- tramadol (a strong painkiller).
- tramadol (snažni lijek protiv bolova).
Vortioxetine did not separate from placebo on subjective measures when evaluated using the Cognitive and Physical Functioning Questionnaire with results of -8.1 for vortioxetine versus -6.9 for placebo (p=0.086).
Vortioksetin se nije odvojio od placeba u subjektivnim mjerilima, procijenjeno korištenjem Upitnika za kognitivno i fizičko funkcioniranje, s rezultatima od -8,1 za vortioksetin naspram -6,9 za placebo (p=0,086).
H. Lundbeck A/S Tel: +45 36301311(Danija) lietuva@lundbeck.com
Lundbeck A/S Tel: +45 36301311(Danija) lietuva@lundbeck.com
- warfarin, dipyridamole, phenprocoumon, low-dose acetylsalicylic acid (blood thinning medicines).
varfarin, dipiridamol, fenprokumon, niske doze acetilsalicilne kiseline (lijekovi za razrjeđivanje krvi).
Lot See embossed stamp.
Vidjeti otisnuti žig.
Depending on individual patient response, a dose adjustment may be considered (see section 4.2).
Može se razmotriti prilagodba doze ovisno o individualnom odgovoru bolesnika (vidjeti dio 4.2).
Brintellix 5 mg film-coated tablets Brintellix 10 mg film-coated tablets Brintellix 15 mg film-coated tablets Brintellix 20 mg film-coated tablets
Brintellix 5 mg filmom obložene tablete Brintellix 10 mg filmom obložene tablete Brintellix 15 mg filmom obložene tablete Brintellix 20 mg filmom obložene tablete
Haemorrhage (including contusion, ecchymosis, epistaxis, gastrointestinal or vaginal bleeding)
Krvarenje (uključujući kontuziju, ekhimozu, epistaksu, gastrointestinalno ili vaginalno krvarenje)
How to take Brintellix
Kako uzimati Brintellix
In the meta-analyses (ANCOVA, LOCF) of the mean change from baseline in DSST number of correct symbols in all 3 studies, vortioxetine separated from placebo (p<0.05) with a standardised effect size of 0.35.
U meta analizama (ANCOVA, LOCF) srednje promjene od početnih vrijednosti u broju točnih simbola DSST-a u sva 3 ispitivanja, vortioksetin se odvojio od placeba (p<0,05) sa standardiziranom veličinom učinka od 0,35.
- The active substance is vortioxetine.
- Djelatna tvar je vortioksetin.
In one study, vortioxetine was superior to placebo on subjective measures, evaluated using the Perceived Deficits Questionnaire with results of -14.6 for vortioxetine and -10.5 for placebo (p=0.002).
U jednom ispitivanju vortioksetin je bio superioran placebu u subjektivnim mjerilima, procijenjeno korištenjem Upitnika za primijećene deficite, s rezultatima od -14,6 za vortioksetin i -10,5 za placebo (p=0,002).
2D barcode carrying the unique identifier included.
17. JEDINSTEVENI IDENTIFIKATOR - 2D BARKOD Sadrži 2D barkod s jedinstvenim identifikatorom.
Suomi/Finland
Suomi/Finland Oy H.
Co-administration of strong inhibitors of CYP3A4 (such as itraconazol, voriconazole, clarithromycin, telithromycin, nefazodone, conivaptan and many of the HIV protease inhibitors) and inhibitors of CYP2C9 (such as fluconazole and amiodarone) to CYP2D6 poor metabolisers (see section 5.2) has not been investigated specifically, but it is anticipated that it will lead to a more marked increased exposure of vortioxetine in these patients as compared to the moderate effect described above.
Istodobna primjena snažnih CYP3A4 inhibitora (kao što su itrakonazol, vorikonazol, klaritromicin, telitromicin, nefazodon, konivaptan i mnogi od inhibitora HIV proteaze) i CYP2C9 inhibitora (kao što su flukonazol i amiodaron) kod slabih metabolizatora CYP2D6 (vidjeti dio 5.2) nije posebno ispitivana, ali se predviđa da će to dovesti do značajnijeg povećanja izloženosti ovih bolesnika vortioksetinu u usporedbi s umjerenim učinkom opisanim iznad.
Based on the above, it was considered that anaphylactic reaction should be included as an adverse drug reaction in the product information of vortioxetine.
Na temelju navedenog smatra se da anafilaktička reakcija treba biti navedena kao nuspojava u informacijama o lijeku za vortioksetin.
For doses of 20 mg vortioxetine once daily, the incidences of nausea and constipation were higher in patients aged ≥65 years (42% and 15%, respectively) than in patients aged <65 years (27% and 4%, respectively)(see section 4.4).
Incidencija mučnine i konstipacije kod doza od 20 mg vortioksetina jednom dnevno je bila viša kod bolesnika u dobi ≥ 65 godina (42% odnosno 15%) nego kod bolesnika u dobi < 65 godina (27% odnosno 4%) (vidjeti dio 4.4).
The starting and recommended dose of Brintellix is 10 mg vortioxetine once daily in adults less than 65 years of age.
Početna i preporučena doza Brintellixa je 10 mg vortioksetina jednom dnevno u odraslih osoba u dobi manjoj od 65 godina.
Your doctor will treat you cautiously if you have a history of fits or have unstable fit disorders/epilepsy.
Vaš liječnik će Vas liječiti oprezno ako imate napadaje ili nestabilni poremećaj s napadajima/epilepsiju u povijesti bolesti.
Following a single dose of 10 mg vortioxetine, no impact of mild or moderate hepatic impairment (Child-Pugh Criteria A or B; n=8 per group) was observed on the pharmacokinetics of vortioxetine (changes in AUC were less than 10%).
Nakon jedne doze vortioksetina od 10 mg, nije opažen utjecaj blagog ili umjerenog oštećenja jetre (Child-Pugh kriteriji A ili B; n=8 po skupini) na farmakokinetiku vortioksetina (promjene u AUC-u bile su manje od 10%).
20 mg corresponding to 20 drops.
20 mg odgovara 20 kapi.
However, by recommended patient usage vortioxetine is considered to pose negligible risk to the aquatic and terrestrial environment (see section
Međutim, smatra se da vortioksetin pri preporučenoj primjeni kod bolesnika predstavlja zanemariv rizik za vodeni i zemljani okoliš (vidjeti dio 6.6).
Post-marketing experience mainly concerns vortioxetine overdoses of up to 80 mg.
Razdoblje nakon stavljanja lijeka u promet uglavnom se odnosi na predoziranje vortioksetinom do 80 mg.
The European Medicines Agency has waived the obligation to submit the results of studies in major depressive disorder with vortioxetine in children aged less than 7 years (see section 4.2 for information on paediatric use).
Europska agencija za lijekove je izuzela obvezu podnošenja rezultata ispitivanja lijeka vortioksetin kod velike depresivne epizode u djece mlađe od 7 godina (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
There is limited experience with vortioxetine overdoses above 80 mg.
Iskustvo s predoziranjem vortioksetinom iznad 80 mg je ograničeno.
Additionally, the class warning on haemorrhage should be updated, to add that haemorrhage has been reported with vortioxetine as well.
Nadalje, potrebno je ažurirati upozorenje vezano uz skupinu te u njega dodati da je krvarenje prijavljeno i za vortioksetin.
No inhibitory effect of 40 mg single-dose omeprazole (CYP2C19 inhibitor) was observed on the multiple-dose pharmacokinetics of vortioxetine in healthy subjects.
Nije opažen inhibitorni učinak jedne doze od 40 mg omeprazola (inibitor CYP2C19) na farmakokinetiku višekratnih doza vortioksetina u zdravih ispitanika.
MINIMUM PARTICULARS TO APPEAR ON BLISTERS BLISTER FOR TABLETS
PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP BLISTER ZA TABLETE
The changes in the kidney in rats (glomerulonephritis, renal tubular obstruction, crystalline material in renal tubule) and in the liver of mice and rats (hepatocellular hypertrophy, hepatocyte necrosis, bile duct hyperplasia, crystalline material in bile ducts) were seen at exposures more than 10-fold (mice) and 2-fold (rats) the human exposure at the maximum recommended therapeutic dose of 20 mg/day.
Opažene su promjene na bubrezima u štakora (glomerulonefritis, opstrukcija bubrežnih tubula, kristalični materijal u bubrežnim tubulima) i promjene na jetri u miševa i štakora (hepatocelularna hipertrofija, nekroza hepatocita, hiperplazija žučovoda, kristalični materijal u žučovodu) kod izloženosti koja je veća 10 puta (miševi) i 2 puta (štakori) od izloženosti ljudi pri maksimalnim preporučenim terapeutskim dozama od 20 mg dnevno.
These findings were mainly attributed to rodent-specific vortioxetine-related crystalline material obstruction of the renal tubules and the bile ducts, respectively, and considered of low risk to humans.
Ova otkrića su uglavnom pripisivana opstrukciji bubrežnih tubula i žučnih vodova kristaličnom tvari specifičnom za glodavce i povezanom s vortioksetinom, te se smatraju niskim rizikom za ljude.
Irreversible, selective MAO-B inhibitor (selegiline, rasagiline) Although a lower risk of serotonin syndrome is expected with selective MAO-B inhibitors than with MAO-A inhibitors, the combination of vortioxetine with irreversible MAO-B inhibitors, such as selegiline or rasagiline should be administered with caution.
Iako se sa selektivnim MAO-B inhibitorima očekuje manji rizik od serotoninskog sindroma nego s MAO-A inhibitorima, kombinaciju vortioksetina s ireverzibilnim MAO-B inhibitorima, poput selegilina ili razagilina, treba primjenjivati s oprezom.
Therefore, vortioxetine should be introduced cautiously in patients who have a history of seizures or in patients with unstable epilepsy (see section 4.5).
Stoga liječenje vortioksetinom treba započeti oprezno u bolesnika s anamnezom napadaja ili u bolesnika s nestabilnom epilepsijom (vidjeti dio 4.5).
In the meta-analysis, the overall mean difference to placebo across the studies was statistically significant: -2.3 points (p = 0.007), -3.6 points (p <0.001), and -4.6 points (p <0.001) for the 5, 10, and 20 mg/day doses, respectively; the 15 mg/day dose did not separate from placebo in the meta-analysis, but the mean difference to placebo was -2.6 points.
U meta analizama, ukupna srednja razlika od placeba kroz ispitivanja je bila statistički značajna: -2,3 boda (p=0,007), -3,6 bodova (p < 0,001 i -4,6 bodova (p < 0,001) za doze od 5, 10 odnosno 20 mg dnevno; doza od 15 mg dnevno se nije udaljila od placeba u meta analizi, ali je razlika od placeba bila -2,6 bodova.
In clinical studies, sexual dysfunction was assessed using the Arizona Sexual Experience Scale (ASEX).
U kliničkim ispitivanjima je spolna disfunkcija bila ocjenjena Arizona ljestvicom spolnog iskustva (engl.
No effect on the pharmacokinetics of vortioxetine or ethanol and no significant impairment, relative to placebo, in cognitive function were observed when vortioxetine in a single dose of 20 mg or 40 mg was co-administered with a single dose of ethanol (0.6 g/kg) in healthy subjects.
Nije bio opažen učinak na farmakokinetiku vortioksetina ili alkohola kao ni značajno pogoršanje kognitivne funkcije u usporedbi s placebom, kada su pojedinačne doze vortioksetina od 20 mg ili 40 mg bile istodobno primjenjene s pojedinačnom dozom etanola (0,6 g/kg) u zdravih ispitanika.
The exposure to vortioxetine increased 2.3-fold for area under the curve (AUC) when vortioxetine 10 mg/day was co-administered with bupropion (a strong CYP2D6 inhibitor 150 mg twice daily) for 14 days in healthy subjects.
Izloženost vortioksetinu povećala je površinu ispod krivulje (AUC) 2,3 puta kada je vortioksetin 10 mg/dan bio istodobno primijenjen s bupropionom (snažnim inhibitorom CYP2D6 150 mg dvaput dnevno) tijekom 14 dana u zdravih ispitanika.
The combination of vortioxetine with a weak reversible and non-selective MAOI, such as the antibiotic linezolid, is contraindicated (see section 4.3).
Kontraindicirana je kombinacija vortioksetina i slabog reverzibilnog i neselektivnog MAOI-a kao što je antibiotik linezolid (vidjeti dio 4.3).
- if you are taking other medicines for depression known as non-selective monoamine oxidase inhibitors or selective MAO-A inhibitors.
- ako uzimate druge lijekove za depresiju, kao što su neselektivni inhibitori monoaminooksidaze ili selektivni MAO-A inhibitori.
Depending on individual patient response, a lower dose of vortioxetine may be considered if a strong inhibitor of CYP3A4 or CYP2C9 is co-administered in CYP2D6 poor metabolisers.
Ovisno o individualnom odgovoru bolesnika, može se razmotriti niža doza vortioksetina ako će se snažni inhibitor CYP3A4 ili CYP2C9 istodobno primijeniti kod slabih metabolizatora CYP2D6.
In elderly healthy subjects (aged ≥65 years; n=20), the exposure to vortioxetine increased up to 27% (Cmax and AUC) compared to young healthy control subjects (aged ≤45 years) after multiple doses of
U starijih zdravih ispitanika (u dobi ≥65 godina; n=20), izloženost vortioksetinu povećala se do 27% (Cmax i AUC) u usporedbi s mladim zdravim kontrolnim ispitanicima (u dobi ≤45 godina) nakon višekratnih doza od 10 mg/dan.
Do not use this medicine after the expiry date that is stated on the packaging after EXP.
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na pakiranju iza oznake „Rok valjanosti“ ili kratice „EXP“.
In clinical studies in children and adolescents treated with other antidepressants, suicide-related behaviour (suicide attempt and suicidal thoughts) and hostility (predominantly aggression, oppositional behaviour, anger) were more frequently observed than in those treated with placebo.
U kliničkim ispitivanjima češće je opaženo ponašanje povezano sa samoubojstvom (pokušaj samoubojstva i suicidalne misli) i netrpeljivost (najviše agresija, opozicijsko ponašanje, bijes) u djece i adolescenata liječenih drugim antidepresivima, nego u onih koji su primali placebo.
Serotonin Syndrome symptoms include mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g., hyperreflexia, uncoordination) and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhoea).
Simptomi serotoninskog sindroma uključuju promjene mentalnog statusa (npr. agitaciju, halucinacije, komu), autonomnu nestabilnost (npr. tahikardiju, nestabilni krvni tlak, hipertermiju), neuromuskularne aberacije (npr., hiperrefleksiju, nekoordinaciju) i/ili gastrointestinalne simptome (npr. mučninu, povraćanje, proljev).
No inhibitory or inducing effect of vortioxetine was observed in the drug-drug interaction studies for the CYP isozymes CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4/5 (see section 4.5).
Nije opažen inhibirajući ili induktorni učinak vortioksetina u ispitivanjima interakcije na CYP izoenzime CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 ili CYP3A4/5 (vidjeti dio 4.5).
Consequently, it was concluded that rash should be included as an adverse drug reaction in the product information of vortioxetine.
Posljedično tome, zaključeno je da osip treba biti naveden kao nuspojava u informacijama o lijeku za vortioksetin.
High-density polyethylene (HDPE) tablet container.
Spremnik za tablete od polietilena visoke gustoće (HDPE).
Co-administration of medicinal products with serotonergic effect (e.g., tramadol, sumatriptan and other triptans) may lead to serotonin syndrome (see section 4.4).
Istodobna primjena lijekova sa serotonergičkim učinkom (npr., tramadol, sumatriptan i drugi triptani) može dovesti do serotoninskog sindroma (vidjeti dio 4.4).
What you need to know before you take Brintellix Do not take Brintellix:
Što morate znati prije nego počnete uzimati Brintellix
Doses of 5 to 15 mg showed no difference to placebo.
Pokazano je da nema razlike u usporedbi s placebom za doze od 5 do 15 mg.
Overdose signs could be dizziness, nausea, diarrhoea, stomach discomfort, itching of the whole body, sleepiness and flushing.
Znakovi predoziranja mogu biti omaglica, mučnina, proljev, nelagoda u trbuhu, svrbež cijelog tijela, pospanost i crvenilo uz osjećaj vrućine.
Uncommon: may affect up to 1 in 100 people - flushing - night sweats
Manje često: mogu se javiti u do 1 na 100 osoba - Navale crvenila - noćno znojenje
Also, no significant inhibitory effect, relative to placebo, on platelet aggregation or pharmacokinetics of acetylsalicylic acid or salicylic acid was observed when acetylsalicylic acid 150 mg/day was co-administered following multiple doses of vortioxetine administration in healthy subjects.
Također, nije opažen značajni inhibitorni učinak u odnosu na placebo na agregaciju trombocita ili farmakokinetiku acetilsalicilne ili salicilne kiseline, kada je acetilsalicilna kiselina 150 mg/dan istodobno primijenjena nakon višestrukih doza vortioksetina u zdravih ispitanika.
Class effect
Učinak skupine
No effect of multiple doses of acetylsalicylic acid 150 mg/day on the multiple-dose pharmacokinetics of vortioxetine was observed in healthy subjects.
Nije opažen učinak višekratnih doza acetilsalicilne kiseline od 150 mg/dan na farmakokinetiku višekratnih doza vortioksetina u zdravih ispitanika.
- if you are taking other medicines known for depression as non-selective monoamine oxidase inhibitors or selective MAO-A inhibitors.
- ako uzimate druge lijekove za depresiju, kao što su neselektivni inhibitori monoaminooksidaze ili selektivni MAO-A inhobitori.
Lundbeck GmbH Tel: +49 40 23649 0
Deutschland Lundbeck GmbH Tel: +49 40 23649 0
Pack sizes of 56 x 1 and 98 x 1 film-coated tablets.
Veličine pakiranja od 56 x 1 i 98 x 1 filmom obloženih tableta.
Brintellix contains the active substance vortioxetine.
Brintellix sadrži djelatnu tvar vortioksetin.
Brintellix is for oral use.
Brintellix je namjenjen za peroralnu primjenu.
No dose adjustment is needed (see section 4.2).
Nije potrebna prilagodba doze (vidjeti dio 4.2).
For the 20 mg/day dose, an increase in TESD was seen compared to placebo (an incidence difference of 14.2%, 95% CI [1.4, 27.0]).
Opaženo je povećanje spolne disfunkcije koja se javila tijekom liječenja u usporedbi s placebom (razlika u incidenciji od 14,2%, 95% CI [1,4, 27,0]) za doze od 20 mg/dan.
Brintellix oral drops, solution, are available in 20 ml amber glass bottle including screw cap with dropper (child-resistant closure).
Brintellix oralne kapi, otopina su dostupne u jantarnim staklenim bocama od 20 ml sa zatvaračem s navojem i kapaljkom (zatvarač siguran za djecu).
Caution is advised when concomitantly using other medicinal products capable of lowering the seizure threshold [e.g. antidepressants (tricyclics, SSRIs, SNRIs), neuroleptics (phenothiazines, thioxanthenes and butyrophenones), mefloquine, bupropion, tramadol] (see section 4.4).
Savjetuje se oprez pri istodobnoj primjeni drugih lijekova koji mogu sniziti prag napadaja [npr. antidepresiva (triciklika, SSRI-a, SNRI-a), neuroleptika (fenotiazina, tioksantena i butirofenona), meflokina, bupropiona, tramadola] (vidjeti dio 4.4).
However, as adverse reactions such as dizziness have been reported, patients should exercise caution when driving or operating hazardous machinery, especially when starting treatment with vortioxetine or when changing the dose.
Međutim, kako su prijavljene nuspojave kao što je omaglica, bolesnici bi trebali biti oprezni pri upravljanju vozilima ili opasnim strojevima, osobito pri početku liječenja vortioksetinom ili pri promjeni doze.
The tablet can be taken with or without food.
Tabletu možete uzeti sa ili bez hrane.
The lowest effective dose of 5 mg vortioxetine once daily should always be used as the starting dose in patients ≥ 65 years of age (see section 4.2).
Najniža učinkovita doza od 5 mg vortioksetina, se uvijek mora koristiti kao početna doza kod bolesnika u dobi ≥65 godina (vidjeti dio 4.2).
5 mg corresponding to 5 drops.
5 mg odgovara 5 kapi.
However, caution should be exercised when prescribing to elderly patients at doses higher than 10 mg vortioxetine once daily (see section 4.4).
Međutim, oprez se savjetuje kada se vortioksetin propisuje starijim bolesnicima u dozama višim od 10 mg jednom dnevno (vidjeti dio 4.4).
Treatment should be discontinued in any patient who develops seizures or for whom there is an increase in seizure frequency.
Liječenje treba prekinuti u svakog bolesnika koji razvije napadaje ili kod koga se poveća učestalost napadaja.
Lundbeck Limited Tel: +44 1908 64 9966
United Kingdom Lundbeck Limited Tel: +44 1908 64 9966
Therefore, caution should be exercised when treating patients ≥ 65 years of age with doses higher than 10 mg vortioxetine once daily (see sections 4.2, 4.8 and 5.2).
≥ 65 godina dozama višim od 10 mg vortioksetina jednom dnevno (vidjeti dijelove 4.2, 4.8 i 5.2).
No dose adjustment is needed (see section 4.4).
Nije potrebna prilagodba doze (vidjeti dio 4.4).
Following multiple doses of vortioxetine, no inhibitory effect was observed in healthy subjects for the cytochrome P450 isozymes CYP2C19 (omeprazole, diazepam), CYP3A4/5 (ethinyl estradiol, midazolam), CYP2B6 (bupropion), CYP2C9 (tolbutamide, S-warfarin), CYP1A2 (caffeine) or CYP2D6 (dextromethorphan).
Nakon primjene višekratnih doza vortioksetina u zdravih ispitanika nije opažen inhibitorni učinak za izoenzime CYP2C19 (omeprazol, diazepam), CYP3A4/5 (etinil estradiol, midazolam), CYP2B6 (bupropion), CYP2C9 (tolbutamid, S-varfarin), CYP1A2 (kofein) ili CYP2D6 (dekstrometorfan) citokroma P450.
The lowest effective dose of 5 mg vortioxetine once daily should always be used as the starting dose in patients ≥ 65 years of age.
Najniža učinkovita doza od 5 mg vortioksetina jednom dnevno, se uvijek mora koristiti kao početna doza kod bolesnika u dobi
No significant impairment, relative to placebo, in cognitive function was observed for vortioxetine following co-administration with a single 10 mg dose of diazepam.
Nije bilo opaženo značajno pogoršanje kognitivne funkcije u usporedbi s placebom, nakon istodobne primjene vortioksetina i jedne doze od 10 mg diazepama.
CYP2D6 gene types
CYP2D6 genotipi
How to store Brintellix
Kako čuvati Brintellix